Search

everythinglearnresearchcommunity

for

Search:↓

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Transplant success has improved with better immunosuppressive drugs and donor matching.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Transplant patients often get skin problems, with treatments varying by condition.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Clofazimine may be effective for treating ashy dermatosis.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Clofazimine effectively treated ashy dermatosis in a patient.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Targeted immunotherapy could be a promising new treatment for hair regrowth.